- Home
- TPST vs SRXH Comparison
TPST vs SRXH Comparison
Compare TPST & SRXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- SRXH
- Stock Information
- Founded
- TPST 2011
- SRXH 2013
- Country
- TPST United States
- SRXH Canada
- Employees
- TPST N/A
- SRXH N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- SRXH
- Sector
- TPST Health Care
- SRXH
- Exchange
- TPST Nasdaq
- SRXH NYSE
- Market Cap
- TPST 33.0M
- SRXH 7.4M
- IPO Year
- TPST N/A
- SRXH N/A
- Fundamental
- Price
- TPST $7.71
- SRXH $0.43
- Analyst Decision
- TPST Hold
- SRXH
- Analyst Count
- TPST 3
- SRXH 0
- Target Price
- TPST $30.00
- SRXH N/A
- AVG Volume (30 Days)
- TPST 94.5K
- SRXH 609.9K
- Earning Date
- TPST 08-07-2025
- SRXH 05-15-2025
- Dividend Yield
- TPST N/A
- SRXH N/A
- EPS Growth
- TPST N/A
- SRXH N/A
- EPS
- TPST N/A
- SRXH N/A
- Revenue
- TPST N/A
- SRXH $119,421,918.00
- Revenue This Year
- TPST N/A
- SRXH $26.28
- Revenue Next Year
- TPST N/A
- SRXH $25.00
- P/E Ratio
- TPST N/A
- SRXH N/A
- Revenue Growth
- TPST N/A
- SRXH 26.27
- 52 Week Low
- TPST $5.35
- SRXH $0.42
- 52 Week High
- TPST $28.34
- SRXH $3.73
- Technical
- Relative Strength Index (RSI)
- TPST 59.30
- SRXH N/A
- Support Level
- TPST $7.13
- SRXH N/A
- Resistance Level
- TPST $8.75
- SRXH N/A
- Average True Range (ATR)
- TPST 0.45
- SRXH 0.00
- MACD
- TPST 0.13
- SRXH 0.00
- Stochastic Oscillator
- TPST 63.83
- SRXH 0.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.